CoreCap Advisors’s VanEck Biotech ETF BBH Stock Holding History

CoreCap Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$46.5K	Hold	190	–	–	﹤0.01%	1442
2026 Q2	$38.6K	Hold	190	–	–	﹤0.01%	1515
2026 Q1	$35.7K	Hold	190	–	–	﹤0.01%	1453
2025 Q4	$36K	Hold	190	–	–	﹤0.01%	1460
2025 Q3	$31.5K	Hold	190	–	–	﹤0.01%	1499
2025 Q2	$29.1K	Hold	190	–	–	﹤0.01%	1470
2025 Q1	$29.9K	Hold	190	–	–	﹤0.01%	1379
2024 Q4	$29.8K	Hold	190	–	–	﹤0.01%	1393
2024 Q3	$33.7K	Hold	190	–	–	﹤0.01%	1348
2024 Q2	$32K	Hold	190	–	–	﹤0.01%	768
2024 Q1	$31.6K	Buy	+190	New	+$31.5K	﹤0.01%	1289
2022 Q3	–	Sell	-3	Closed	–	–	667
2022 Q2	$0	Buy	+3	New	+$447	﹤0.01%	2127
2022 Q1	–	Sell	-26	Closed	-$5K	–	678
2021 Q4	$5K	Buy	+26	New	+$5.01K	﹤0.01%	1739

Other funds holding BBH

Paragon Private Wealth Management Lexington, Kentucky $326M AUM 26.55% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.08B AUM 12.02% 1-Year Est. Return

HFAS

Hummer Financial Advisory Services Chicago, Illinois $153M AUM 19.62% 1-Year Est. Return

Value Investment Professionals New York $115M AUM 13% 1-Year Est. Return

Cyndeo Wealth Partners St. Petersburg, Florida $2.21B AUM 17.29% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Plan A Wealth Lincoln, Nebraska $280M AUM 16.85% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Focus Financial Network Minneapolis, Minnesota $3.3B AUM 21.52% 1-Year Est. Return

BigSur Wealth Management Miami, Florida $423M AUM 18.98% 1-Year Est. Return

CoreCap Advisors's BBH Position: Q3 2026 in Review

CoreCap Advisors held its VanEck Biotech ETF (BBH) position steady in Q3 2026 at 190 shares worth $46.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

CoreCap Advisors first reported a position in BBH in Q4 2021 and has held it in 13 quarters since. 16 funds tracked by Wall St. Rank hold BBH as of Q3 2026.

CoreCap Advisors held 190 shares of VanEck Biotech ETF worth $46.5K as of Q3 2026.
CoreCap Advisors left its VanEck Biotech ETF share count unchanged in Q3 2026.
VanEck Biotech ETF made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1442 holding.
CoreCap Advisors first reported a position in VanEck Biotech ETF in Q4 2021 and has held it in 13 quarters since.
16 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.